CSTL - CONFLUENCE SUPPORT AT $37 IF IT GETS THEREAll,
Castle looks like it would bounce pretty huge here at $37 double support. However, not in a bad spot now to reverse. Just wait and see clerly taking a beating.
−2.15USD
−57.47 MUSD
219.79 MUSD
25.60 M
About Castle Biosciences, Inc.
Sector
Industry
CEO
Derek J. Maetzold
Website
Headquarters
Friendswood
Employees (FY)
610
Founded
2007
ISIN
US14843C1053
FIGI
BBG006YWVSR3
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Castle Biosciences Awarded U.S. Federal Supply Schedule ContractCSTL: Castle Biosciences, Inc.
2021-08-24 07:00:00
Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
Stock To WatchThe Market keeps grinding sideways with the longer term uptrend still intact, many growth names remain choppy. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these char
CASTLE BiosciencesTHE STOCK is following market structure and it work buying also at the 50-47 level with the main of hitting the target which have marked
$CSTL Double Bottom Buy?I've had this on my watch list for some time now. It looks ready to break the short term down trend line out of a double bottom pattern. I have an alert set to tell me when it hits the trend line which is just over the $50 mark and it would retake the 50 day MA... I also like the buying volume that
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CSTL is 18.94 USD — it has decreased by 1.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Castle Biosciences, Inc. stocks are traded under the ticker CSTL.
Castle Biosciences, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
CSTL stock is 2.38% volatile and has beta coefficient of 0.90. Check out the list of the most volatile stocks — is Castle Biosciences, Inc. there?
One year price forecast for Castle Biosciences, Inc. has a max estimate of 37.00 USD and a min estimate of 28.00 USD.
CSTL earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.76 USD resulting in a 65.97% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Castle Biosciences, Inc. earnings.
Castle Biosciences, Inc. revenue for the last quarter amounts to 60.61 M USD despite the estimated figure of 48.57 M USD. In the next quarter revenue is expected to reach 56.28 M USD.
Yes, you can track Castle Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
CSTL stock has fallen by 8.55% compared to the previous week, the month change is a 2.42% fall, over the last year Castle Biosciences, Inc. has showed a 18.82% decrease.
CSTL net income for the last quarter is −2.58 M USD, while the quarter before that showed −6.91 M USD of net income which accounts for 62.64% change. Track more Castle Biosciences, Inc. financial stats to get the full picture.
Today Castle Biosciences, Inc. has the market capitalization of 527.04 M, it has decreased by 6.04% over the last week.
No, CSTL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CSTL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Castle Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 610.00 employees. See our rating of the largest employees — is Castle Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Castle Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Castle Biosciences, Inc. stock shows the sell signal. See more of Castle Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Castle Biosciences, Inc. future price: according to them, CSTL price has a max estimate of 37.00 USD and a min estimate of 28.00 USD. Read a more detailed Castle Biosciences, Inc. forecast: see what analysts think of Castle Biosciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Castle Biosciences, Inc. EBITDA is −55.65 M USD, and current EBITDA margin is −25.32%. See more stats in Castle Biosciences, Inc. financial statements.